Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial
2020 ◽
Vol 21
(5)
◽
pp. 655-663
◽
Sarah B Goldberg
◽
Kurt A Schalper
◽
Scott N Gettinger
◽
Amit Mahajan
◽
Roy S Herbst
◽
...
2016 ◽
Vol 17
(7)
◽
pp. 976-983
◽
Sarah B Goldberg
◽
Scott N Gettinger
◽
Amit Mahajan
◽
Anne C Chiang
◽
Roy S Herbst
◽
...
2019 ◽
Vol 185
(5)
◽
pp. 874-882
◽
Melody R. Becnel
◽
Loretta J. Nastoupil
◽
Felipe Samaniego
◽
Richard E. Davis
◽
M. J. You
◽
...
2012 ◽
Vol 13
(5)
◽
pp. 459-465
◽
Kim Margolin
◽
Marc S Ernstoff
◽
Omid Hamid
◽
Donald Lawrence
◽
David McDermott
◽
...
Minesh Mehta
◽
Manmeet Ahluwalia
2018 ◽
Vol 36
(15_suppl)
◽
pp. 9520-9520
◽
Laurent Mortier
◽
Philippe Jamme
◽
Jean Philippe Lacour
◽
Caroline Robert
◽
Thierry Lesimple
◽
...
2017 ◽
Vol 18
(7)
◽
pp. 863-873
◽
Michael A Davies
◽
Philippe Saiag
◽
Caroline Robert
◽
Jean-Jacques Grob
◽
Keith T Flaherty
◽
...
Jin-Hua Liang
◽
Li Wang
◽
Hua-Yuan Zhu
◽
Jun Qian
◽
Hui Liao
◽
...
Close
Export Citation Format
Close
Share Document
Close